InflaRx will also conduct one-on-one investor meetings on February 11 th. A link to view the fireside chat live stream and its replay is available here. Oppenheimer 36th Annual Healthcare Life ...
Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.
An immunotherapy reduces plaque in the arteries of mice, offering a potential new strategy to treat cardiovascular disease, ...
Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart ...
Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart disease. The antibody-based therapy could complement ...
Omeros Corporation today announced that the first commercial shipments of YARTEMLEA® (narsoplimab-wuug) to its distributors were completed last week, with orders from transplant centers beginning that ...
AstraZeneca entered a strategic collaboration with CSPC Pharmaceuticals to expand its weight management and metabolic disease ...
Cash-rich Cullinan Therapeutics stock: zipalertinib NDA in Q1 2026 plus CLN-978 and CLN-049 AML catalysts. Read here for more analysis.
The Body Optimist on MSN
Alzheimer's: A sound frequency opens a promising avenue of research
New research suggests that sound at a specific frequency could help the brain "clean up" deposits associated with Alzheimer's ...
Allergic diseases represent a major global health burden, placing significant strain on health care systems worldwide. Severe ...
Thinking positive increased a specific brain region's activity and might have heightened immune response after a shot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results